| Breakdown | TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 151.78B | 150.53B | 134.68B | 146.80B | 133.28B | 97.11B |
| Gross Profit | 62.99B | 62.45B | 54.76B | 61.83B | 53.51B | 36.91B |
| EBITDA | 39.62B | 39.63B | 32.09B | 37.21B | 33.40B | 19.76B |
| Net Income | 25.31B | 25.64B | 19.38B | 23.63B | 21.44B | 12.18B |
Balance Sheet | ||||||
| Total Assets | 229.98B | 240.19B | 227.70B | 209.03B | 190.29B | 161.56B |
| Cash, Cash Equivalents and Short-Term Investments | 49.15B | 54.54B | 36.78B | 40.08B | 49.03B | 43.66B |
| Total Debt | 17.80B | 20.08B | 25.17B | 14.19B | 5.50B | 7.58B |
| Total Liabilities | 56.35B | 63.96B | 69.27B | 63.00B | 59.20B | 44.77B |
| Stockholders Equity | 172.62B | 175.17B | 157.64B | 145.36B | 130.51B | 116.26B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 19.25B | -4.95B | -7.05B | 14.49B | 16.20B |
| Operating Cash Flow | 0.00 | 28.82B | 4.89B | 1.00B | 23.84B | 22.06B |
| Investing Cash Flow | 0.00 | 2.54B | -10.56B | -8.42B | -8.99B | -5.19B |
| Financing Cash Flow | 0.00 | -13.99B | 1.62B | -2.17B | -10.35B | -8.28B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
81 Outperform | ¥3.01T | 25.03 | 53.12% | 1.11% | 32.51% | 57.19% | |
79 Outperform | ¥18.49T | 33.18 | 26.01% | 1.79% | 16.74% | 16.03% | |
78 Outperform | ¥1.80T | 15.60 | 21.73% | 2.29% | 11.29% | 11.38% | |
77 Outperform | ¥605.02B | 24.84 | 12.66% | 2.28% | 9.53% | -11.17% | |
77 Outperform | ¥16.34T | 45.29 | 47.37% | 0.25% | 63.36% | 149.43% | |
75 Outperform | ¥7.37T | 35.55 | 25.78% | 0.79% | 13.45% | 20.37% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% |